BioSpace News Archive

Rich Preyer and Marilyn Jacobs Preyer of Hillsborough, North Carolina, have donated $1 million to support the latest phase of UNC Lineberger Comprehensive Cancer Center’s Carolina Breast Cancer Study, which is investigating how the causes, treatments and long-term outcomes of breast cancer differ between Black women and white women.

Exo Therapeutics, Inc., a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets, announced the completion of a $78 million Series B financing.

Participating Investors include Viva BioInnovator, Eli Lilly and Company, Opaleye Management, Orange Grove Bio and Alexandria Venture Investments Foundational Science Stems From Landmark Research at Weill Cornell Medicine and Hospital for Special Surgery (HSS)

Innodem Neurosciences announced today that it has signed a multi-year partnership agreement with Novartis Pharmaceuticals Canada Inc. (Novartis) to conduct a breakthrough clinical trial to help people living with multiple sclerosis (MS).

Potrero Medical, today announced that Joe Urban, CEO, will present during the Jefferies Private MedTech Summit on Wednesday, October 6, 2021.

Company Expands Leadership Team with Appointment of Nazareth Martinez Shedden as Vice President, Strategic Finance

On October 21th at 9AM PST / 12PM EST , Dr. Kelly Wosnik , Owner/ NP-C of Bristol Health will share practice patterns and associated clinical implications using pharmacogenomic testing (PGx) to pinpoint the right treatments for mental illnesses.

Data Shows Statistically Significant Improvements in Speed and Motor Function in PD Patients.

Gator Bio, Inc. announced the launch of the Gator™ SMAP probe and Gator™ mFC probe for GatorPrime and GatorPlus biolayer interferometry (BLI) systems today.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and IVUS solutions, today announced that a worldwide committee of 40 cross-specialty medical experts achieved the first-ever consensus for the appropriate use of intravascular ultrasound (IVUS) in peripheral vascular disease (PVD) interventions.